Keryx Biopharmaceuticals is categorized under Wholesale Pharmaceutical Products in Cambridge, MA and active since 2004.
Keryx Biopharmaceuticals was established in 2004, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Wholesale Pharmaceutical Products business, which does work in the B2B market, and is classified as a Wholesale Pharmaceutical Products, under code number 424210 by the NAICS.
If you are seeking more information, feel free to contact Benjamin Corn at the company’s single location by writing to 101 Main St # 17, Cambridge, Massachusetts MA 02142 or by phoning (617) 995-0933. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Keryx Biopharmaceuticals |
| Contact Person: | Benjamin Corn |
| Address: | 101 Main St # 17, Cambridge, Massachusetts 02142 |
| Phone Number: | (617) 995-0933 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2004 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Wholesale Pharmaceutical Products |
| SIC Code: | 5122 |
| NAICS Code: | 424210 |
| Share This Business: |
Keryx Biopharmaceuticals was started in 2004 to provide professional Wholesale Pharmaceutical Products under the SIC code 5122 and NAICS code 424210. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Benjamin Corn for inquiries that concern Keryx Biopharmaceuticals by calling the company number (617) 995-0933, as your correspondence is most welcome. Additionally, the physical location of the single location of Keryx Biopharmaceuticals can be found at the coordinates 42.362266,-71.082345 as well as the street address 101 Main St # 17 in Cambridge, Massachusetts 02142.
For its online presence, you may visit Keryx Biopharmaceuticals’s website at and engage with its social media outlets through on Twitter and on Facebook.